Evidence map›Paper›PMID 42397462›Full record

ArticleMolecular biology reports2026

A case study of comprehensive association analysis and risk prediction of amyotrophic lateral sclerosis in a Chinese population.

Xueying Xie, Xiaoqing Jiao, Ke Yang, Qianqian Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xueying XieSchool of Chemistry and Biological Engineering, University of Science and Technology, Beijing, 100083, China.
Xiaoqing JiaoSchool of Chemistry and Biological Engineering, University of Science and Technology, Beijing, 100083, China.
Ke YangSchool of Chemistry and Biological Engineering, University of Science and Technology, Beijing, 100083, China.
Qianqian ZhangSchool of Chemistry and Biological Engineering, University of Science and Technology, Beijing, 100083, China. zhangqianqian186@hotmail.com.

Funding

National Natural Science Foundation of China Grant Number: 32302711
6 · The paper itself

Abstract

backgroundAmyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease with significant genetic heterogeneity. While large-scale studies have characterized its genetic architecture in European populations, the genetic basis of ALS in the Chinese population remains under-explored. METHODS AND

resultsTo address this gap, we conducted a comprehensive genetic analysis on a cohort of 40 Chinese individuals (32 ALS patients and 8 controls) using whole genome sequencing. We employed the Phenotype-Covariate Genetic Correlation method to estimate SNP-based heritability on the liability scale and utilized LDAK-KVIK for gene-based association analysis. Our analysis revealed a SNP-based heritability (h

conclusionsThis study provides the first comprehensive estimate of SNP-based heritability in a sequenced Chinese ALS cohort and supports the "polygenic background" hypothesis. The identification of candidate risk genes and the preliminary validation of polygenic risk scoring highlight the potential for future genetic stratification in Chinese patients.

Indexed as

Amyotrophic Lateral SclerosisAdultAgedCase-Control StudiesChinaEast Asian PeopleFemaleGene FrequencyGenetic Association StudiesGenetic Predisposition to DiseaseGenetic Risk ScoreGenome-Wide Association StudyHumansMaleMiddle AgedMultifactorial InheritanceAmyotrophic Lateral Sclerosis (ALS)Genome-Wide Association Study (GWAS)HeritabilityPolygenic Risk Score (PRS)

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.